Through combined cancer genomic mutation analysis and gene expression analysis, A3B upregulation is significantly associated with immune gene expression, and A3B expression positively correlates with known immunotherapy response biomarkers, including PD-L1 expression and T-cell infiltration in NSCLC (figure 4) [133]. This evidence concerns the gene CD274 and cancer.